Cellromax Science Co., Ltd.

471820 · KQ · Healthcare / Pharmaceutical Retailers

3,785.00KRW-20.00 (-0.53%)

Price History

Full chart

Market Stats

Previous Close3,805.00

Open3,780.00

Day Range3,770.00 – 3,785.00

52-Week Range3,410.00 – 7,466.06

Volume223

Market Cap45.30B

P/E (TTM)0.00

Forward P/E0.00

Dividend Yield4.49%

50-Day Avg4,047.60

200-Day Avg4,844.15

About

Cellromax Science Co., Ltd. focuses to merge with other companies. The company was founded in 2022 and is based in Seoul, South Korea.

Company Details

SectorHealthcare
IndustryPharmaceutical Retailers
Headquarters56 Yeoui-daero, Seoul, South Korea, Korea
Websitehttps://hanwha-plus-no3spac.com

Financials

Income Statement

Currency: KRW	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	21.09B	19.31B	21.63B	22.18B
Growth (%)	-	-8.42%	+12.02%	+2.56%
Cost of Revenue	11.23B	9.55B	9.35B	11.64B
Gross Profit	9.85B	9.76B	12.28B	10.55B
Gross Margin	46.73%	50.52%	56.79%	47.54%
Operating Expense	3.24B	5.14B	6.78B	7.71B
Operating Income	6.61B	4.62B	5.50B	2.84B
Operating Margin	31.35%	23.92%	25.43%	12.78%
EBITDA	6.29B	6.03B	5.61B	3.98B
EBITDA Margin	29.83%	31.22%	25.93%	17.94%
Net Income	4.73B	4.50B	3.82B	2.97B
Net Income Margin	22.44%	23.30%	17.65%	13.37%
Interest Expense	5.80M	23.24M	37.77M	50.49M
Interest Expense % of Total Revenue	0.03%	0.12%	0.17%	0.23%

Balance Sheet

Currency: KRW	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	28.53B	32.83B	49.10B	50.91B
Total Liabilities	2.76B	2.71B	4.58B	3.99B
Total Equity	25.77B	30.11B	44.52B	46.92B
Cash	250.01M	1.92B	1.05B	678.33M

Cash Flow

Currency: KRW	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	5.52B	5.07B	6.29B	1.79B
Capital Expenditure	131.21M	682.56M	2.75B	179.28M
Free Cash Flow	5.39B	4.38B	3.54B	1.61B
Dividends Paid	-	-	-	3.39B
FCF to OCF	97.62%	86.53%	56.25%	89.96%
Dividend Paid to FCF	-	-	-	211.03%

Earnings

Report Date	Dec 31, 2024	Mar 31, 2025	Jun 30, 2025	Sep 30, 2025	Dec 31, 2025	Mar 31, 2026	Jun 30, 2026
EPS Estimate	-	-	-	-	-	-	-
EPS Actual	-90.92	64.18	101.43	66.65	28.23	106.54	72.25
Surprise	-	-	-	-	-	-	-
Timing	-	-	-	-	-	-	-

Key Statistics & Ratios

Market Cap45.30B

Enterprise Value35.08B

Trailing P/E0.00

Forward P/E0.00

Price / Sales2.31

Price / Book0.94

Revenue (TTM)19.60B

Gross Profit (TTM)9.81B

EBITDA2.60B

Profit Margin15.65%

Operating Margin19.29%

Return on Equity6.77%

Return on Assets2.72%

Shares Outstanding10.99M

Shares Float2.07M

Dividend Yield4.49%

Dividend Rate185.00

Payout Ratio54.81%

Dividends

20262×

50.00Jun 29, 202650.00Mar 30, 2026

20253×

50.00Dec 29, 202535.00Sep 29, 2025101.05Jun 27, 2025

20241×

166.73Dec 27, 2024

Stock Splits

Sep 9, 20250.9896:1